Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.530
+0.020 (0.80%)
Sep 13, 2024, 4:00 PM EDT - Market closed
Puma Biotechnology Employees
Puma Biotechnology had 185 employees as of December 31, 2023. The number of employees decreased by 7 or -3.65% compared to the previous year.
Employees
185
Change (1Y)
-7
Growth (1Y)
-3.65%
Revenue / Employee
$1,184,557
Profits / Employee
$47,135
Market Cap
124.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Harvard Bioscience | 416 |
Veru Inc. | 189 |
Adicet Bio | 143 |
Inventiva | 123 |
Kodiak Sciences | 111 |
Myomo | 106 |
Assertio Holdings | 53 |
Eton Pharmaceuticals | 30 |
PBYI News
- 10 days ago - Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 5 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Puma Biotechnology Reports Second Quarter Financial Results - Business Wire
- 2 months ago - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results - Business Wire
- 3 months ago - Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Business Wire
- 3 months ago - Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) - Business Wire
- 3 months ago - Puma Biotechnology to Join Russell 3000 Index - Business Wire